American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will hold a conference call to discuss its fourth quarter and full year 2025 financial results on March 31, 2026, at 12:00 PM ET. The financial results press release will be issued before the market opens on the same day.
The announcement is significant as it provides investors and stakeholders with insights into the company's performance over the past year, particularly in its core segments of equipment leasing and direct patient care services. The call will offer a detailed look at financial metrics, operational achievements, and strategic direction, which are crucial for understanding the company's position in the competitive cancer treatment market.
To participate in the conference call, domestic callers can dial 1-844-413-3972, and international callers can dial 1-412-317-5776, at least ten minutes before the start time. Participants should ask to join the American Shared Hospital Services call. A simultaneous webcast will be accessible through the company's website at www.ashs.com or directly via this link.
A replay of the call will be available from approximately one hour after the conclusion until April 7, 2026. To access the replay, dial 1-855-669-9658 or 1-412-317-0088, using access code 6331493. The replay will also be archived on the company's website.
American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The company collaborates with partners to develop and grow cancer service lines, offering integrated cancer care in local settings. For centers under health system partnerships, the company and its partners share capital investment costs and profitability based on ownership interests.
The upcoming financial results will reflect the company's performance amid ongoing market challenges and opportunities. Investors will be keen to assess the impact of reimbursement rate changes, operational expansions, and strategic acquisitions on financial outcomes. The conference call serves as a platform for management to address these factors and outline future growth initiatives.
